A Multi-targeted Approach to Suppress Tumor-Promoting Inflammation

Cancers harbor significant genetic heterogeneity and patterns of relapse following many therapies are due to evolved resistance to treatment. While efforts have been made to combine targeted therapies, significant levels of toxicity have stymied efforts to effectively treat cancer with multi-drug co...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Semin Cancer Biol
Autores principales: Samadi, Abbas K., Georgakilas, Alexandros G., Amedei, Amedeo, Amin, Amr, Bishayee, Anupam, Lokeshwar, Bal L., Grue, Brendan, Panis, Carolina, Boosani, Chandra S., Poudyal, Deepak, Stafforini, Diana M., Bhakta, Dipita, Niccolai, Elena, Guha, Gunjan, Rupasinghe, H.P. Vasantha, Fujii, Hiromasa, Honoki, Kanya, Mehta, Kapil, Aquilano, Katia, Lowe, Leroy, Hofseth, Lorne J., Ricciardiello, Luigi, Ciriolo, Maria Rosa, Singh, Neetu, Whelan, Richard L., Chaturvedi, Rupesh, Ashraf, S. Salman, Kumara, HMC Shantha, Nowsheen, Somaira, Mohammed, Sulma I., Helferich, William G., Yang, Xujuan
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4635070/
https://ncbi.nlm.nih.gov/pubmed/25951989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2015.03.006
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares